4.6 Article

An overview of meta-analyses on radiomics: more evidence is needed to support clinical translation

期刊

INSIGHTS INTO IMAGING
卷 14, 期 1, 页码 -

出版社

SPRINGER WIEN
DOI: 10.1186/s13244-023-01437-2

关键词

Radiomics; Quality improvement; Systematic review; Meta-analysis

向作者/读者索取更多资源

This study provides an overview of the meta-analyses of radiomics studies, evaluating their quality and evidence level. The systematic reviews on radiomics were found to have suboptimal quality, and only a limited number of radiomics approaches were supported by convincing level of evidence.
Objective To conduct an overview of meta-analyses of radiomics studies assessing their study quality and evidence level. Methods A systematical search was updated via peer-reviewed electronic databases, preprint servers, and systematic review protocol registers until 15 November 2022. Systematic reviews with meta-analysis of primary radiomics studies were included. Their reporting transparency, methodological quality, and risk of bias were assessed by PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) 2020 checklist, AMSTAR-2 (A MeaSurement Tool to Assess systematic Reviews, version 2) tool, and ROBIS (Risk Of Bias In Systematic reviews) tool, respectively. The evidence level supporting the radiomics for clinical use was rated. Results We identified 44 systematic reviews with meta-analyses on radiomics research. The mean +/- standard deviation of PRISMA adherence rate was 65 +/- 9%. The AMSTAR-2 tool rated 5 and 39 systematic reviews as low and critically low confidence, respectively. The ROBIS assessment resulted low, unclear and high risk in 5, 11, and 28 systematic reviews, respectively. We reperformed 53 meta-analyses in 38 included systematic reviews. There were 3, 7, and 43 meta-analyses rated as convincing, highly suggestive, and weak levels of evidence, respectively. The convincing level of evidence was rated in (1) T2-FLAIR radiomics for IDH-mutant vs IDH-wide type differentiation in low-grade glioma, (2) CT radiomics for COVID-19 vs other viral pneumonia differentiation, and (3) MRI radiomics for high-grade glioma vs brain metastasis differentiation. Conclusions The systematic reviews on radiomics were with suboptimal quality. A limited number of radiomics approaches were supported by convincing level of evidence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据